AI-SUPPORTED PRE-MORTEM ANALYSIS FOR HEOR STRATEGIES: LESSONS FROM PROJECT MANAGEMENT SCIENCE OBJECTIVES

Author(s)

Shilpi Swami, MSc1, Tushar Srivastava, MSc1, Hanan Irfan, MSc2, Kunal Swami, MASc, MSc2.
1ConnectHEOR, London, United Kingdom, 2ConnectHEOR, Delhi, India.
OBJECTIVES: Pre-mortem analysis, a structured method from project management science, is used to identify failure risks before implementation. This study explored the application of AI-supported pre-mortem analysis to HEOR strategy development, with the aim of anticipating methodological, evidence, and HTA risks earlier in the decision lifecycle.
METHODS: A conceptual framework was developed integrating pre-mortem methodology with AI-supported scenario generation. HEOR strategies (e.g., evidence generation plans, modelling approaches, HTA submission strategies) were decomposed into key assumptions and decision points. An AI system was used to generate hypothetical failure scenarios based on historical HTA decisions, methodological guidance, and documented HEOR risks. Outputs were categorized into risk domains including evidence sufficiency, methodological alignment, stakeholder interpretation, and implementation feasibility. Expert review assessed plausibility and usefulness of identified risks.
RESULTS: The AI-supported pre-mortem analysis identified a broad range of potential failure modes, including misalignment between trial endpoints and HTA expectations, overreliance on immature evidence, structural weaknesses in modelling assumptions, and vulnerabilities in value narratives. Many risks aligned with issues observed retrospectively in failed or delayed HTA submissions. Experts reported that the approach helped surface implicit assumptions and encouraged earlier mitigation planning, though prioritization and contextual judgement remained human-led.
CONCLUSIONS: AI-supported pre-mortem analysis offers a structured approach to proactively identifying HEOR strategy risks before downstream investment and submission. When combined with expert interpretation, this method may enhance strategic robustness, reduce late-stage HTA failure, and support more resilient evidence generation planning.

Conference/Value in Health Info

2026-09, ISPOR Asia Pacific 2026, Bangkok, Thailand

Value in Health, Volume 55, Issue S1

Code

MSR30

Topic

Methodological & Statistical Research

Topic Subcategory

Artificial Intelligence, Machine Learning, Predictive Analytics

Disease

No Additional Disease & Conditions/Specialized Treatment Areas

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×